Trial intelligence / Profile preview

Rotigotine for Nocturnal Blood Pressure in RLS

NCT01455012Phase 4Completed

Sponsor
UCB
Start
Sep 2011
Primary completion
May 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rotigotine in restless legs syndrome (RLS), sponsored by UCB. Started Sep 2011; status: completed.

02

Drugs

rotigotine
03

Conditions

restless legs syndrome (RLS)

Beyond the preview

Go deeper on NCT01455012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01455012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call